Abiopharma

🔍 Lefkowitz Steven W (Director)

Company: CorMedix Inc. (CRMD)

Report Date: 2026-01-12

Detailed Transactions and Holdings:

• Acquired 15,000 shares of Common Stock at $5.63 per share (Direct)
  Date: 2026-01-12 | Code: M | equity_swap_involved: 0 | shares_owned_after: 95,498.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-12 | Code: H | nature_of_ownership: Wade Capital Corporation Money Purchase Plan | shares_owned_after: 30,152.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-12 | Code: H | nature_of_ownership: Reporting Person's Wife | shares_owned_after: 2,000.00
• Sold 15,000 shares of Stock Option (Right to Buy Common Stock) at $5.63 per share (Derivative)
  Date: 2026-01-12 | Code: M | Expires: 2030-02-25 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: The Reporting Person acquired stock through the exercise of options granted on 02/25/2020. The Reporting Person paid the exercise price in cash. No sales of stock were made.
• F2: The Reporting Person beneficially owns these securities through Wade Capital Corporation Money Purchase Plan (an entity for which the Reporting Person has voting and investment control).
• F3: These stock options, representing a right to purchase 15,000 shares of Common Stock, were granted on 02/25/2020. These stock options are fully vested.
• REMARKS: Exhibit 24.1 - Power of Attorney